Financial projections from AngioDynamics (NSDQ:ANGO) about its $372 million deal to acquire Navilyst Medical show that it expects to reap some significant rewards from the merger over the short and long terms.
Orasi Medical Inc.
University of Minnesota-spinoff Orasi Medical Inc. raised $1.8 million from the sale of equity, according to a Securities & Exchange Commission filing.
Overall, the software startup hopes to raise $2.6 million by December.
CEO Shawn Lyndon declined to comment, citing SEC rules that prohibit public comments on fundraising activities.
The company, which generates less than $1 million a year in revenue, is developing software designed to help pharmaceuticals makers speed the development of drugs targeting neurological diseases, like Alzheimer’s.